• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial for "a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators".

作者信息

Soleimani Yaser, Khatibmasjedi Seyedehhoda, Javadinia Seyed Alireza, Shenavaei Zare Sara, Chaman Reza

机构信息

Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Palliative care department, Case Western Reserve University, University Hospitals, Seidman Cancer Center, Cleveland, Ohio, USA.

出版信息

Future Sci OA. 2025 Dec;11(1):2527486. doi: 10.1080/20565623.2025.2527486. Epub 2025 Jul 1.

DOI:10.1080/20565623.2025.2527486
PMID:40590337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12218414/
Abstract
摘要

相似文献

1
Editorial for "a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators".关于“基于血液指标的PD-1抑制剂治疗的ESCC患者irAEs预测模型”的社论
Future Sci OA. 2025 Dec;11(1):2527486. doi: 10.1080/20565623.2025.2527486. Epub 2025 Jul 1.
2
Neutrophil to Lymphocyte Ratio as a Biomarker for the Prediction of Cancer Outcomes and Immune-Related Adverse Events in a CTLA-4-Treated Population.中性粒细胞与淋巴细胞比值作为预测CTLA-4治疗人群癌症预后及免疫相关不良事件的生物标志物
Cancers (Basel). 2025 Jun 17;17(12):2011. doi: 10.3390/cancers17122011.
3
[Clinical Features of PD-1/PD-L1 Inhibitors-Related Thyroid Dysfunction in Lung Cancer Patients and Their Predictive Value for Therapeutic Efficacy].[肺癌患者中PD-1/PD-L1抑制剂相关甲状腺功能障碍的临床特征及其对治疗疗效的预测价值]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):514-520. doi: 10.12182/20250360104.
4
Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.可切除食管鳞状细胞癌中含或不含PD-1/PD-L1抑制剂的新辅助化疗：一项基于随机对照试验的荟萃分析
BMC Gastroenterol. 2025 May 29;25(1):416. doi: 10.1186/s12876-025-04030-7.
5
Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitors.中性粒细胞与淋巴细胞比值以及不良事件前后中性粒细胞与淋巴细胞比值对接受PD-(L)1抑制剂治疗的癌症患者免疫相关不良事件和细菌感染的鉴别诊断价值。
J Leukoc Biol. 2025 May 7;117(5). doi: 10.1093/jleuko/qiaf029.
6
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.非人类免疫缺陷病毒免疫重建炎症综合征与免疫相关不良事件的免疫发病机制比较：一项前瞻性多中心队列研究。
J Dermatol. 2025 Jun;52(6):1015-1030. doi: 10.1111/1346-8138.17706. Epub 2025 Mar 29.
7
Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study.嗜酸性粒细胞是肾细胞癌患者接受伊匹木单抗联合纳武单抗治疗所致严重免疫相关不良事件的预测指标：一项回顾性多中心队列研究。
Front Immunol. 2025 Jan 9;15:1483956. doi: 10.3389/fimmu.2024.1483956. eCollection 2024.
8
Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis.免疫检查点抑制剂在转移性或早期三阴性乳腺癌一线治疗中的应用：一项系统评价和网络荟萃分析。
Front Endocrinol (Lausanne). 2023 May 9;14:1137464. doi: 10.3389/fendo.2023.1137464. eCollection 2023.
9
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.基线中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值似乎可预测肝细胞癌免疫治疗相关毒性。
World J Gastrointest Oncol. 2023 Nov 15;15(11):1900-1912. doi: 10.4251/wjgo.v15.i11.1900.
10
Immune checkpoint inhibitors' combination therapy as first-line treatment in advanced esophageal squamous cell carcinoma: a meta-analysis.免疫检查点抑制剂联合疗法作为晚期食管鳞状细胞癌的一线治疗：一项荟萃分析
J Cancer Res Clin Oncol. 2023 Mar;149(3):933-939. doi: 10.1007/s00432-022-04066-2. Epub 2022 Jun 25.

本文引用的文献

1
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.外周血细胞计数作为接受免疫检查点抑制剂的癌症患者免疫相关不良事件的预测指标：一项系统评价和荟萃分析。
Front Immunol. 2025 Jan 30;16:1528084. doi: 10.3389/fimmu.2025.1528084. eCollection 2025.
2
Exploring novel immunotherapy in advanced esophageal squamous cell carcinoma: Is targeting TIGIT an answer?探索晚期食管鳞状细胞癌的新型免疫疗法：靶向TIGIT是否是答案？
Esophagus. 2025 Apr;22(2):139-147. doi: 10.1007/s10388-024-01105-4. Epub 2025 Jan 23.
3
Prognostic value of immuno-inflammatory biomarkers in esophageal squamous cell carcinoma patients receiving immunotherapy combined with chemoradiotherapy and its association with immuno-genomic landscape.免疫炎症生物标志物在接受免疫治疗联合放化疗的食管鳞状细胞癌患者中的预后价值及其与免疫基因组格局的关联
BMC Cancer. 2024 Dec 18;24(1):1518. doi: 10.1186/s12885-024-13298-z.
4
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.二线纳武利尤单抗单药治疗不可切除或转移性食管癌的预后因素：184 例多机构队列研究。
J Gastroenterol. 2024 Nov;59(11):979-985. doi: 10.1007/s00535-024-02141-8. Epub 2024 Aug 17.
5
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.免疫检查点抑制剂联合治疗不可切除或转移性食管癌的真实世界数据：一项多机构队列研究。
Int J Clin Oncol. 2024 Jul;29(7):994-1001. doi: 10.1007/s10147-024-02532-0. Epub 2024 Apr 28.
6
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors.免疫检查点抑制剂治疗的癌症患者免疫相关不良反应的预测生物标志物。
BMC Immunol. 2024 Jan 24;25(1):8. doi: 10.1186/s12865-024-00599-y.
7
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.基线中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值似乎可预测肝细胞癌免疫治疗相关毒性。
World J Gastrointest Oncol. 2023 Nov 15;15(11):1900-1912. doi: 10.4251/wjgo.v15.i11.1900.
8
Determination of sputum eosinophil count and serum absolute eosinophil count in patients with bronchial asthma and its correlation with disease severity and response to treatment.支气管哮喘患者痰液嗜酸性粒细胞计数和血清嗜酸性粒细胞绝对计数的测定及其与疾病严重程度和治疗反应的相关性。
J Family Med Prim Care. 2023 Sep;12(9):2053-2057. doi: 10.4103/jfmpc.jfmpc_487_23. Epub 2023 Sep 30.
9
Blood cell counts can predict adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis.血细胞计数可预测免疫检查点抑制剂的不良事件：系统评价和荟萃分析。
Front Immunol. 2023 Mar 7;14:1117447. doi: 10.3389/fimmu.2023.1117447. eCollection 2023.
10
Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis.免疫疗法治疗晚期或转移性食管鳞癌患者的疗效和安全性比较：系统评价和网络荟萃分析。
BMC Cancer. 2022 Sep 17;22(1):992. doi: 10.1186/s12885-022-10086-5.